Debaki Ranjan Howlader

6PUBLICATIONS
10CO-AUTHORS
Medical infection agents (incl. prions)Host-parasite interactionsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)Infant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 04, 2026
A multivalent subunit vaccine augments pre-existing immunity to protect against T3SS-positive Pseudomonas aeruginosa but reveals immunological interference against ExlA-positive strains.

|Jul 02, 2026
Third-generation cephalosporin-induced L-form transition in Shigella sonnei reveals a virulence-survival trade-off underlying persistent infection.

|Aug 06, 2025
A High-throughput Multi-Species Platform Using Biolayer Interferometry Immunosorbent Assay (BLI-ISA) as an Alternative to Indirect ELISA for Vaccine Development.

Ti Lu, Md Shafiullah Parvej, Sean K Whittier

|Jun 27, 2024
Vaccination with a Protective Ipa Protein-Containing Nanoemulsion Differentially Alters the Transcriptomic Profiles of Young and Elderly Mice following Shigella Infection.

Ti Lu, Murugesan Raju, Debaki R Howlader

|Apr 27, 2024
Shigella Vaccines: The Continuing Unmet Challenge.

Ti Lu, Sayan Das, Debaki R Howlader

|Mar 15, 2023
A protein subunit vaccine elicits a balanced immune response that protects against Pseudomonas pulmonary infection.

Debaki R Howlader, Sayan Das, Ti Lu

Pageof 1

Frequent Collaborators

3 joint publications

Robert K Ernst

2 joint publications

Wendy L Picking

2 joint publications

William D Picking

1 joint publications

Rahul Shubhra Mandal